Andrea Lampis

5.5k total citations · 1 hit paper
38 papers, 1.7k citations indexed

About

Andrea Lampis is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Andrea Lampis has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Pathology and Forensic Medicine and 14 papers in Cancer Research. Recurrent topics in Andrea Lampis's work include Genetic factors in colorectal cancer (13 papers), Colorectal Cancer Treatments and Studies (11 papers) and Cancer Genomics and Diagnostics (7 papers). Andrea Lampis is often cited by papers focused on Genetic factors in colorectal cancer (13 papers), Colorectal Cancer Treatments and Studies (11 papers) and Cancer Genomics and Diagnostics (7 papers). Andrea Lampis collaborates with scholars based in Italy, United Kingdom and Switzerland. Andrea Lampis's co-authors include Nicola Valeri, Margherita Ratti, Jens C. Hahne, Michele Ghidini, Milko Mirchev, Jens Claus Hahne, Massimiliano Salati, Federica Perrone, Marco A. Pierotti and Rodolfo Passalacqua and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Andrea Lampis

38 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside

2020 357 citations Margherita Ratti, Andrea Lampis et al. Targeted Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Lampis Italy	18	702	655	655	567	353	38	1.7k
Akira Ooki Japan	20	617 0.9×	595 0.9×	303 0.5×	456 0.8×	155 0.4×	98	1.4k
Caterina Vivaldi Italy	18	760 1.1×	346 0.5×	403 0.6×	512 0.9×	143 0.4×	101	1.3k
Yingqiang Shi China	21	335 0.5×	1.1k 1.6×	933 1.4×	614 1.1×	168 0.5×	53	1.9k
Emanuele Canestrari Italy	22	1.6k 2.2×	811 1.2×	548 0.8×	682 1.2×	683 1.9×	38	2.3k
Bunzo Nakata Japan	25	1.0k 1.5×	561 0.9×	367 0.6×	420 0.7×	222 0.6×	76	1.7k
Agoston T. Agoston United States	19	507 0.7×	691 1.1×	231 0.4×	386 0.7×	320 0.9×	37	1.7k
Soon‐Myoung Kang Japan	11	522 0.7×	703 1.1×	368 0.6×	349 0.6×	123 0.3×	17	1.2k
Raija Ristamäki Finland	21	760 1.1×	535 0.8×	307 0.5×	230 0.4×	226 0.6×	52	1.3k
Raed Moh’d Taiseer Al-Rajabi United States	14	1.1k 1.5×	388 0.6×	232 0.4×	520 0.9×	218 0.6×	54	1.7k

Countries citing papers authored by Andrea Lampis

Since Specialization

Citations

This map shows the geographic impact of Andrea Lampis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Lampis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Lampis more than expected).

Fields of papers citing papers by Andrea Lampis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Lampis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Lampis. The network helps show where Andrea Lampis may publish in the future.

Co-authorship network of co-authors of Andrea Lampis

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Lampis. A scholar is included among the top collaborators of Andrea Lampis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Lampis. Andrea Lampis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ratti, Margherita, Andrea Lampis, Michele Ghidini, et al.. (2020). MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Targeted Oncology. 15(3). 261–278. 357 indexed citations breakdown →

Hahne, Jens C., Andrea Lampis, & Nicola Valeri. (2020). Vault RNAs: hidden gems in RNA and protein regulation. Cellular and Molecular Life Sciences. 78(4). 1487–1499. 42 indexed citations

Lampis, Andrea, Jens C. Hahne, Somaieh Hedayat, & Nicola Valeri. (2020). MicroRNAs as mediators of drug resistance mechanisms. Current Opinion in Pharmacology. 54. 44–50. 19 indexed citations

Anandappa, Gayathri, Andrea Lampis, David Cunningham, et al.. (2019). Prospective analysis of microRNA 31-3p (miR31-3p) as a predictive biomarker of response to anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies (mABs) in patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 37(4_suppl). 548–548. 2 indexed citations

Ratti, Margherita, Andrea Lampis, Jens C. Hahne, Rodolfo Passalacqua, & Nicola Valeri. (2018). Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cellular and Molecular Life Sciences. 75(22). 4151–4162. 160 indexed citations

Ghidini, Michele, Jens C. Hahne, Melissa Frizziero, et al.. (2018). MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours. Targeted Oncology. 13(4). 423–436. 4 indexed citations

Mensah, Afua A., Luciano Cascione, Eugenio Gaudio, et al.. (2018). Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma. Haematologica. 103(12). 2049–2058. 14 indexed citations

Ghidini, Michele, Luciano Cascione, Pietro Carotenuto, et al.. (2017). Characterisation of the immune-related transcriptome in resected biliary tract cancers. European Journal of Cancer. 86. 158–165. 45 indexed citations

Smyth, Elizabeth, Matteo Fassan, David Cunningham, et al.. (2016). Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Journal of Clinical Oncology. 34(23). 2721–2727. 206 indexed citations

10.

Sclafani, Francesco, Ian Chau, David Cunningham, et al.. (2016). KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial. Annals of Oncology. 27. vi173–vi173. 1 indexed citations

11.

Ghidini, Michele, Francesco Trevisani, Matteo Fassan, et al.. (2015). Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs). Annals of Oncology. 26. vi96–vi96. 1 indexed citations

12.

Trevisani, Francesco, Paolo Manunta, Jens C. Hahne, et al.. (2015). SP299MICRORNA-200B AS PREDICTIVE BIOMARKER OF CHRONIC KIDNEY DISEASE (CKD) IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY. Nephrology Dialysis Transplantation. 30(suppl_3). iii478–iii478. 1 indexed citations

13.

Molinari, Francesca, Stefano Signoroni, Andrea Lampis, et al.. (2014). BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.. PubMed. 100(3). 315–20. 6 indexed citations

14.

Perrone, Federica, Andrea Lampis, Cláudia Bertan, et al.. (2014). Circulating Free DNA in a Screening Program for Early Colorectal Cancer Detection. Tumori Journal. 100(2). 115–121. 33 indexed citations

15.

Pietrantonio, Filippo, Federica Perrone, Pamela Biondani, et al.. (2013). Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens. Cancer Biology & Therapy. 14(12). 1098–1103. 24 indexed citations

16.

Bartolomeo, Maria Di, Filippo Pietrantonio, Federica Perrone, et al.. (2013). Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT. Targeted Oncology. 9(2). 155–162. 26 indexed citations

17.

Reid, James F., Eugenio Zoni, Andrea Lampis, et al.. (2012). miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation. Molecular Cancer Research. 10(4). 504–515. 114 indexed citations

18.

Bhoori, Sherrie, Sara Toffanin, Carlo Sposito, et al.. (2010). Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle. Journal of Hepatology. 52(5). 771–775. 65 indexed citations

19.

Barisella, Marta, Andrea Lampis, Federica Perrone, & Antonino Carbone. (2008). Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: Case report with molecular analysis. World Journal of Gastroenterology. 14(42). 6575–6575. 14 indexed citations

20.

Perrone, Federica, Andrea Lampis, Marta Orsenigo, et al.. (2008). PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Annals of Oncology. 20(1). 84–90. 337 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact